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Abstract
In response to oxygen limitation or oxidative and nitrosative stress, bacteria express three kinds of hemoglobin proteins: truncated
hemoglobins (tr Hbs), hemoglobins (Hbs) and flavohemoglobins (flavo Hbs). The two latter groups share a high sequence homology and
structural similarity in their globin domain. Flavohemoglobin proteins contain an additional reductase domain at their C-terminus and
their expression is induced in the presence of reactive nitrogen and oxygen species. Flavohemoglobins detoxify NO in an aerobic process,
termed nitric oxide dioxygenase reaction, which protects the host from various noxious nitrogen compounds. Only a small number of
bacteria express hemoglobin proteins and the best studied of these is from Vitreoscilla sp. Vitreoscilla hemoglobin (VHb) has been
expressed in various heterologous hosts under oxygen-limited conditions and has been shown to improve growth and productivity,
rendering the protein interesting for biotechnology industry. The close interaction of VHb with the terminal oxidases has been shown and
this interplay has been proposed to enhance respiratory activity and energy production by delivering oxygen, the ultimate result being an
improvement in growth properties.
6 2003 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
Keywords: Nitrosative stress; Nitric oxide detoxi¢cation; Pathogenic bacteria; Microaerobic growth; Biotechnological application; Protein engineering
Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 526
2. Globin proteins: an overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 526
3. Bacterial Hbs and £avoHbs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 526
3.1. Identi¢cation of Hbs and £avoHbs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 526
3.2. Intracellular localization of VHb and HMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 528
3.3. Structure of bacterial Hbs and £avoHbs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 528
3.4. Biochemical properties of Hbs and £avoHbs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 531
4. Regulation and function of bacterial £avoHbs and Hbs . . . . . . . . . . . . . . . . . . . . . . . . . . 532
4.1. VHb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 532
4.2. E. coli £avoHb HMP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 534
4.3. Regulation and function of S. enterica serovar Typhimurium £avoHb (HmpStm) . . . . 535
4.4. Regulation and function of R. eutropha £avoHb (FHP) . . . . . . . . . . . . . . . . . . . . . . . 535
4.5. B. subtilis £avoHb (HmpBs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 535
4.6. FlavoHbs from various bacterial species . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 536
5. Hbs and £avoHbs in biotechnology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 536
5.1. Use of VHb to improve cell growth and productivity . . . . . . . . . . . . . . . . . . . . . . . . 537
5.2. Novel globin proteins for improved performance in heterologous hosts . . . . . . . . . . . 538
6. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 539
0168-6445 / 03 / $22.00 6 2003 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
doi :10.1016/S0168-6445(03)00056-1
* Corresponding author. Tel. : +41 (1) 633 34 46; Fax: +41 (1) 633 10 51. E-mail address: kallio@biotech.biol.ethz.ch (P.T. Kallio).
1 Present address: Institute of Medical Virology, University of Zu«rich, 8028 Zu«rich, Switzerland.
FEMSRE 789 24-9-03
FEMS Microbiology Reviews 27 (2003) 525^545
www.fems-microbiology.org
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 540
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 540
1. Introduction
The importance of oxygen for life relates to both its
primary use as a substrate and its secondary e¡ects on
metabolism. Its use as a substrate allows cellular metabo-
lism to work at optimal levels of substrate utilization and
energy yield. Oxygen is required for the regulation of a
variety of cellular functions, which are expressed in re-
sponse to oxygen or to the presence of noxious byproducts
that accumulate during the aerobic lifestyle. Oxygen and
cognate oxygen radicals can directly or indirectly a¡ect
bacterial cells in at least two ways: altering the function
of speci¢c proteins or a¡ecting the biosynthesis of speci¢c
sets of proteins. The latter e¡ects are largely due to the
e¡ects of oxygen on the function of global transcription
factors.
In humans, the protein molecule most closely associated
with the utilization of oxygen is hemoglobin (Hb), the
best-characterized oxygen-binding protein both at the
functional and the molecular level. The presence of this
oxygen-binding protein had long been thought to be re-
stricted to mammals, but recent ¢ndings indicate an al-
most ubiquitous existence of Hbs in mammals, non-verte-
brates, plants, and bacteria. This review will address the
current state of knowledge concerning bacterial globin and
their role in cellular metabolism.
2. Globin proteins: an overview
Globins are encountered in all ¢ve kingdoms of life and
are assigned to vertebrate and non-vertebrate Hb classes.
The latter group includes the Hbs present in plants, fungi
and protozoa. The common characteristic of all Hb pro-
teins is their ability to reversibly bind oxygen. Although
the alignment of the amino acid sequences of globins from
various sources reveals a highly variable or even almost
random primary amino acid sequence, two key residues
are conserved among all globin proteins encountered so
far: Phe at position CD1 (topological position, for nomen-
clature see [1]) and His at position F8. Analysis of protein
structures of globins reveals a typical tertiary structure, the
classical globin-fold [2]. This highly conserved structure
consists of six to eight K-helical segments that are con-
nected by short intervening loops. The three-on-three helix
structure forms a sandwich-like assembly and binds the
heme moiety within a cavity surrounded by hydrophobic
residues.
Vertebrate globins are encountered circulating in body
£uids, where they deliver oxygen, or are expressed in
muscle tissues (myoglobin), where they donate oxygen to
the respiring cells. Very recently, two hexacoordinate Hbs
have been discovered in mammals : a Hb present preferen-
tially in the brain called neuroglobin, and an ubiquitously
expressed Hb designated histoglobin or, alternatively, cy-
toglobin [3^5]. Neuroglobin has been suggested to protect
neurons from hypoxic^ischemic injury [6]. Both proteins
show less than 30% identity with either Hb or myoglobin.
Non-vertebrate globins exist in manifold variations
(from monomeric to multisubunit structures) and are
present in widely di¡erent anatomical sites, such as in
the cytoplasm of speci¢c tissues or freely dissolved in var-
ious body £uids. Non-vertebrate globins display a much
higher variability in primary and tertiary structures, which
might re£ect their adaptations to speci¢c functions com-
pared to their vertebrate homologs (reviewed in [7]).
Over the last dozen years, monomeric single domain
globins have been found in symbiont-containing legumi-
nous and non-leguminous plants, algae and a number of
prokaryotes [8^12]. Chimeric globins consisting of an
N-terminal globin domain and an adjacent, C-terminal
redox-active protein domain, collectively called £avohe-
moglobins (£avoHbs), have been discovered in bacteria,
yeasts and fungi [13^16]. Truncated globins (trHbs), which
display a two-on-two helix architecture, are widely distrib-
uted in bacteria, unicellular eukaryotes and plants [17^20]
(reviewed in [21]). TrHbs, which have previously also been
designated as ‘small Hbs’ or myoglobin and ¢rst discov-
ered in 1989 in Paramecium caudatum, have been sug-
gested not to originate from the ancestral Hb, but to
have evolved from a di¡erent protein [17,22].
3. Bacterial Hbs and £avoHbs
3.1. Identi¢cation of Hbs and £avoHbs
The obligate aerobic bacterium Vitreoscilla synthesizes a
homodimeric Hb (VHb) [23]. Initially called cytochrome o,
VHb was believed to be a soluble terminal oxidase in
Vitreoscilla [23,24]. However, spectral, kinetic and struc-
tural properties proved the Hb character of this protein
[8,24,25]. VHb is the best-characterized member of the
group of bacterial Hb proteins. The vhb gene has been
isolated and it encodes an oxygen-binding protein of
15.7 kDa [8,26,27]. Interestingly, when VHb was puri¢ed
from Vitreoscilla, an NADH metHb reductase was co-pu-
ri¢ed [24,28]. Early work on VHb has been reviewed else-
where and is therefore not described here [29].
By performing BLAST searches on ¢nished and un¢n-
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ished bacterial genomes using VHb as query sequence,
further bacterial Hb proteins can be readily identi¢ed (Ta-
ble 1). We have isolated the Hb coding genes from Cam-
pylobacter jejuni (CHb) and Clostridium perfringens in our
laboratory and the latter is being characterized currently
[30] (Farre¤s, J., personal communication). CHb has been
analyzed experimentally for its potential use in improving
growth under oxygen limitation or protection from nitro-
sative and oxidative stress [30,31].
The strictly respiratory, denitrifying bacterium Ralstonia
eutropha (formerly Alcaligenes eutrophus) synthesizes an
alternative form of bacterial globin: a £avoHb termed
FHP [13]. The coding sequence for this protein is located
on a plasmid [32]. The fhp gene was isolated from a mega-
plasmid library, using FHP-speci¢c antibodies and oligo-
nucleotide probes based on the N-terminal polypeptide
sequence of a yeast £avoHb, determined previously by
Zhu and Riggs [14]. The fhp gene encodes a soluble mono-
meric polypeptide of 403 amino acids, having a molecular
mass of 44 kDa [33].
The £avoHb from Escherichia coli (HMP) was isolated
in an attempt to identify dihydropteridine reductase activ-
ities and to date it is the best-characterized member of the
£avoHb protein family [34].
FlavoHbs from Erwinia chrysanthemi, Bacillus subtilis,
Salmonella enterica serovar Typhimurium and Mycobacte-
rium tuberculosis have been isolated and characterized [35^
39]. Other £avoHb proteins have recently been cloned
from Deinococcus radiodurans, Pseudomonas aeruginosa,
Klebsiella pneumoniae and S. enterica serovar Typhi (Ta-
ble 1) [30]. FlavoHbs typically possess a molecular mass of
approximately 44 kDa.
Table 1
Compilation of bacterial Hb* and £avoHb genesa
Organism Gene Length (bp) Reference/accession number
Aquifex aeolicus * 420 AE000678.1
Campylobacter jejuni NCTC11168 chb* 423 [30] ; AL139079
Clostridium perfringens hyp27 Cp-hb* 435 Farre¤s, J.b ; AB028630
Novosphingobium aromaticivorans * 450 NZ_AAAV01000175.1
Rhodopseudomonas palustris * 426 NZ_AAAF01000001.1
Vitreoscilla sp. vhb* 441 [26,27] ; M30794
Azotobacter vinelandii 1182 NZ_AAAD01000087.1
Bacillus anthracis A2012 1209 NC_003995.1
Bacillus halodurans C-125 hmpBh 1236 Farre¤s, J.bÞ ; AB024563
Bacillus subtilis 168trpC2 hmpBs 1200 [37] ; D78189
Burkholderia fungorum 1245 NZ_AAAC01000178.1
Burkholderia sp. TH2 1182 AB035325.1
Corynebacterium glutamicum ATCC 13032 1161 NC_003450.2
Deinococcus radiodurans hmpDr 1212 [30] ; AE001863
Erwinia chrysanthemi hmpX 1188 [158] ; X75893
Escherichia coli MG1655 hmp 1191 [34] ; X58872
Magnetospirillum magnetotacticum 1242 NZ_AAAP01001552.1
Nostoc punctiforme 1320 NZ_AABC01000078.1
Oceanobacillus iheyensis 1221 NC_004193.1
Pseudomonas £uorescens 1182 NZ_AABA01000076.1
Pseudomonas aeruginosa PAO1 hmpPa 1182 [30] ; AE004695
Ralstonia eutropha fhp 1212 [33]
Ralstonia metallidurans 1290 NZ_AAAI01000369.1
Ralstonia solanacearum 1206 NC_003295.1
Salmonella enterica serovar Typhi hmpSt 1191 [30] ; AL627275
Salmonella enterica serovar Typhimurium hmpStm 1191 [35] ; AF020388
Shigella £exneri 2a str. 301 1191 NC_004337.1
Sinorhizobium meliloti hmpSm 1212 Farre¤s, J.bÞ ; NC_003037
Staphylococcus aureus N315 1146 AP003129.2
Staphylococcus aureus subsp. aureus MW2 1146 NC_003923.1
Staphylococcus. aureus MU50 1146 NC_002758.1
Streptomyces coelicolor A3 hmpA2 1212 Farre¤s, J.bÞ ; AL354616.1
Streptomyces coelicolor A3 hmpA 1197 Farre¤s, J.bÞ ; AL158061
Streptomyces coelicolor A3 cosmid J11 1308 AL109949.1
Thermobi¢da fusca 1281 NZ_AAAQ01000041.1
Vibrio cholerae 1185 AE004358.1
Vibrio paraha«molyticus 1185 U09005.1
Xylella fastidiosa 9a5c 1194 AE003859.1NC_002488.1
Yersinia pestis OC92 1191 AJ414154.1
aThe deposited genome data can be accessed at http://www.ncbi.nih.gov. Hb-encoding genes and putative Hb sequences are marked with an asterisk *.
bPersonal communication.
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A compilation of bacteria carrying Hb and £avoHb
genes is shown in Table 1. The genes have either been
isolated from these microorganisms or predicted to exist
due to high sequence homology to currently known pro-
teins. The alignment of the primary amino acid sequences
reveals the occurrence of several conserved residues in
both the Hb domain and in the redox-active domain
(Fig. 1). The role of these conserved residues is discussed
below.
3.2. Intracellular localization of VHb and HMP
Studies on the localization of heterologously expressed
VHb in E. coli have revealed a distribution of the protein
into both the cytoplasmic and periplasmic space, with up
to 30% of the active protein being found in the latter [40].
The export of VHb into the periplasm was believed to be
due to the presence of a 16-amino-acid-long sequence at
the N-terminus of VHb that could direct the protein into
the periplasm [40].
Analysis of the amino acid sequence revealed several
unusual features not typically found in bacterial signal
sequences. Instead of having positively charged residues
at its amino terminus, it has a negative charge. The overall
hydrophobicity of the central region of this putative signal
sequence is signi¢cantly lower than that found in typical
leader peptides due to the presence of charged residues not
cleaved during or after the translocation process (since the
region is an intrinsic part of the Hb protein) [40,41]. Fu-
sions of the N-terminal sequence of VHb (16^23 amino
acids) to phoA allowed the export of alkaline phosphatase
into the periplasm of E. coli [40]. A similar distribution of
VHb was observed in Vitreoscilla [40].
Recently, Webster and co-workers [42] analyzed VHb
localization using electron microscopy in Vitreoscilla and
E. coli. The results clearly indicate that VHb has mainly a
cytoplasmic and not a periplasmic localization in both
organisms. The authors suggest that the observed periplas-
mic localization of VHb might be due to the overexpres-
sion and extrusion of VHb and not due to active export
[42]. It cannot be ruled out that the osmotic shock proce-
dure used for the periplasmic sample preparation gener-
ated these putatively false results.
The N-terminal sequence of HMP is highly similar to
that of VHb. HMP has also been found to localize into
both the periplasmic and cytoplasmic spaces of E. coli,
with approximately 30% of the total HMP amount present
in the former. The distribution into cytoplasmic and peri-
plasmic spaces was found in an HMP overproducing
strain as well as in a strain bearing only a single chromo-
somal copy of hmp. In contrast to VHb, spectral analysis
revealed that biochemically active HMP is exclusively
found in the cytoplasmic fraction [43].
3.3. Structure of bacterial Hbs and £avoHbs
3.3.1. Globin domain
The three-dimensional (3D) structures of FHP, HMP
and VHb have been resolved by X-ray crystallography
[44^48]. The Hb domains of FHP, HMP and VHb adopt
the classical globin-fold [2]. The heme molecule is em-
bedded in a hydrophobic crevice formed by helices B, C,
E, F, G and H. A rigid binding between the polypeptide
chain and the porphyrin ring is provided predominantly
by hydrophobic side chains pointing towards the proximal
site of the heme molecule. No protein^heme interactions
are detected at its distal site. A clear di¡erence of these
structures, relative to mammalian Hb, is the lack of helix
D. The residues connecting helices C and E do not adopt
the usual K-helical conformation but rather form a loop.
The observed disorder in the CE region in FHP has been
interpreted as a potential site of interaction between the
globin domain and the FAD module of its reductase do-
main [45]. By analogy, this would provide a potential con-
tact site for VHb with the NADH metHb reductase.
[47,49]. A striking di¡erence between VHb and HMP on
Table 2
Binding of oxygen and nitric oxide to various Hb and £avoHb proteins
Ligand paira Association (mM31 s31) Dissociation (s31) Reference
O2
HMP 38 0.44 [75]
HMP (Tyr-B10CPhe) 50 34 (3.3)b [74]
VHb 78 5000 [25]
200 4.2 (1.5)b [64]
FHP 50 0.2 [75]
NO
HMP (Fe(II)) 26 0.0002 [75]
HMP (Fe(II)) (Tyr-B10CPhe) 33 (2.8)b 0.0001 [74]
FHP (Fe(II)) 10^20 [75]
HMP (Fe(III)) 44 4000 [75]
HMP (Fe(III)) (Tyr-B10CPhe) 42 (5.2)b [74]
FHP (Fe(III)) 2.4 1200 [75]
aLigand-binding pair, O2 exclusively binds to the heme in the ferrous form, whereas NO binds to the ferrous (Fe(II)) and the ferric (Fe(III)) heme iron.
bValue in brackets represents slow phase in a biphasic process.
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one hand and the globin domain of FHP on the other
hand is the displacement of helix E in FHP, opening the
angle between helix E and F. The heme-binding crevice is
therefore enlarged, thus providing more space at the li-
gand-binding site [45]. A phospholipid has been found to
bind inside the hydrophobic crevice, but the function of
this ligand is not known [50]. The negative charge of the
phosphate group, which is positioned between the heme
and the FAD group, is assumed to a¡ect the electrochem-
ical potential of the prosthetic groups and therefore also
the electron transfer between the heme and the FAD moi-
ety. Substitution of Ala-E14 for Tyr prevented phospho-
lipid binding, possibly as a result of the Tyr side chain
protruding into the lipid-binding site. In contrast, HMP
displayed only weak a⁄nity for phospholipids [50]. In
HMP, the cavity formed by the CE loop was found to
         
       
      
       
        
       
       
       
         
       
         
  
         
       
      
       
        
       
       
       
                  
               
               
 
 
         
       
      
       
        
       
       
       
         
       
      
       
        
       
       
       
         
       
      
       
        
       
       
       
 
 
         
       
      
       
        
       
       
       
Fig. 1. Multiple amino acid alignment of £avoHbs and Hbs, which have recently been studied. VHb (Vitreoscilla [26,27]), HmpEc (E. coli, also called
HMP [34]), FHP (R. eutropha [33]), HmpX (E. chrysanthemi [38]), HmpBs (B. subtilis [37]), HmpStm (Salmonella serovar Typhimurium [35,36]), CHb,
HmpPa, HmpDr and HmpSt (C. jejuni, P. aeruginosa, D. radiodurans, Salmonella serovar typhi [30]) and Cp-Hb (C. perfringens (Farre¤s, J., personal
communication)). Annotation of the globin domain is according to the topological positions, in the reductase domain according to the residue number.
Important residues are given in bold. His-F8, Tyr-G5 and Glu-H23 form the catalytic triad at the proximal site. Tyr-B10 and Gln-E7 have been sug-
gested to be involved in the stabilization of heme-bound dioxygen. Residues 206^209 (in FHP) and 204^207 (in HMP) are involved in FAD binding.
Lys-F7, Glu (FHP: 394, HMP: 388) and Tyr (209, 207) are in£uencing the redox potential of the prosthetic heme and FAD groups.
FEMSRE 789 24-9-03
A.D. Frey, P.T. Kallio / FEMS Microbiology Reviews 27 (2003) 525^545 529
harbor an anion, such as chloride or phosphate, which
might participate in modulating the heme iron ligand-
binding properties [48].
A number of residues, which are invariant in all known
sequences, are encountered within the globin domain (Fig.
1). Hydrophobic clusters are formed around Phe-CD1 and
Trp-H7. These two clusters are essential for folding and
stability. The proximal site residues His-F8, Tyr-G5 and
Glu-H23 have been proposed to form a hydrogen bond
network, which might modulate the redox properties of
the heme-iron atom [45]. Indeed, as proposed, the struc-
tural rearrangements at the proximal site relative to the
classical globin-fold resemble the catalytic triad observed
in cytochrome c peroxidase and are a strong support for a
physiologically di¡erent role of £avoHb than pure oxygen
storage and delivery [45,51]. Interpreting Raman spectros-
copy data, it has been suggested that the imidazole ring of
the proximal His-F8 possesses an imidazolate character
due to a strong hydrogen bond to Glu-H23. This proximal
hydrogen-bonding interaction in HMP provides a strong
electronic push for the activation of the heme-bound oxy-
gen [52]. Furthermore, infrared spectra of CO adducts of
HMP and also VHb display an absorption maximum
around 1960 cm31, which is similar to data obtained
from cytochrome CO adducts and di¡erent from CO ad-
ducts of myoglobins [53,54].
Interestingly, Tyr-B10 and Gln-E7, previously suggested
to be involved in heme ligand stabilization, were found to
be shifted away from the heme in unliganded ferric HMP.
Instead, the Leu-E11 side chain, protruding into the distal
site, prevents interaction of Tyr-B10 with the heme ligand.
Previously, the occurrence of two distinct forms of the
distal heme pocket has been proposed: an open conforma-
tion without hydrogen bonding and a closed structure
with strong hydrogen-bonding interactions between ligand
and Tyr-B10 [52]. The resolution of the X-ray structure of
HMP allowed Ilari et al. [48] to modify the above model
and they proposed that a ligand-binding-induced displace-
ment of the Leu-E11 side chain enables approaching and
contacting between the heme ligand and the hydroxyl
group of Tyr-B10 [48]. A similar conformational change
of Leu-E11 was considered necessary for azide and thio-
cyanate binding to ferric VHb, as such a conformational
change was clearly required to make the sixth iron-coor-
dination position accessible for ligand binding [47,55].
Furthermore, Gln-E7 was not found to stabilize iron-
bound ligands through hydrogen bonding in VHb [47].
The latter ¢nding has been con¢rmed by analysis of li-
gand-binding properties of a VHb mutant where Gln-E7
had been replaced by Leu [56].
Whereas for VHb the occurrence of a dimeric form is
well established, Stevanin et al. recently proposed that,
due to the observed cooperativity in cyanide binding,
HMP might also exist as a dimer in vivo [57]. The quater-
nary assembly of homodimeric VHb, which has not been
observed before within the globin family, is based on a
molecular interface de¢ned by helices F and H of both
subunits and essentially involves Van der Waals contacts
among the two subunits. The two heme-iron atoms ap-
proach each other to a distance of 34 AX [47].
3.3.2. Reductase domain
In contrast to the classical globins, £avoHbs contain a
C-terminal redox-active domain with binding sites for
NAD(P)H and FAD. The reductase domain belongs to
the ferredoxin NADPþ reductase-like protein family [58].
The reductase domain can be subdivided into two struc-
turally and functionally independent domains: a FAD-
binding domain (residues 153^258 in FHP, 151^251 in
HMP) and an NAD(P)H-binding domain (residues 266^
403 in FHP, 259^396 in HMP). The former consists of a
six-stranded antiparallel L-barrel, whereas the latter is
built up of a ¢ve-stranded parallel L-sheet, £anked by
two N-terminal helices and one C-terminal helix, respec-
tively. The FAD group non-covalently contacts all three
domains of FHP. Heme and FAD molecules approach
each other to a minimal distance of 6.3 AX (FHP) and
5.9 AX (HMP), respectively, enabling electron transfer
from FAD to the heme moiety in a predominantly polar
environment, provided by several amino acid side chains
[45,48]. The relative spatial orientation of the NAD(P)H-
binding domain is changed, i.e. in HMP it is rotated clock-
wise compared to FHP. This produces a large interdomain
cleft in HMP [48]. However, it is known that the relative
spatial arrangement of FAD- and NAD(P)H-binding do-
mains within members of the ferredoxin NADPþ reduc-
tase-like protein family allows variance without disturbing
the function [58].
Several residues are highly conserved in the reductase
domain of £avoHbs (Fig. 1). Tyr (FHP: 208, HMP:
206) contacts Lys-F7, Glu (FHP: 394, HMP: 388) and
the isoalloxazine ring of FAD; Gln (FHP: 207, HMP:
205) stabilizes a water molecule that bridges FAD and
the heme moiety. Arg (FHP: 206, HMP: 204), Tyr
(FHP: 208, HMP: 206) and Ser (FHP: 209, HMP: 207)
contact the FMN moiety. In the NAD-binding domain,
Glu (FHP: 394, HMP: 388) is highly conserved and its
side chain contacts Lys-F7, forming a salt bridge. Lys-F7
and Glu (FHP: 394, HMP: 388) are part of a number of
polar residues, whose predominantly large side chains
originate from all three domains. These residues may in-
£uence the electrochemical potential of the prosthetic
heme and FAD groups [45], and are considered to be
essential for transport of electrons from FAD to the
heme iron.
Lys-F7 is conserved in VHb, but is replaced by Thr and
Ile in the Hb from C. jejuni and C. perfringens, respec-
tively. The absence of the charged residue in the Hb
from C. jejuni and C. perfringens might therefore prevent
electron transfer from an external reductase, such as the
metHb reductase present in Vitreoscilla, to the heme moi-
ety as proposed for VHb [30].
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3.4. Biochemical properties of Hbs and £avoHbs
Hbs are generally associated with oxygen binding and
transport. Indeed, bacterial Hbs and £avoHbs are able to
reversibly bind molecular oxygen. However, their structur-
al properties (i.e. the occurrence of an intramolecular re-
dox domain in £avoHb and the presence of the catalytic
triad at the distal heme site in both Hb and £avoHb) may
bring into question the role of bacterial Hb and £avoHb in
simple oxygen storage and delivery.
3.4.1. Ligand binding
Bacterial Hb and £avoHb bind various heme ligands,
such as O2, CO, NO and CN3. The observed absorption
spectra are characteristic of Hb proteins [8,59^63]. Where-
as oxygen and CO bind only to the ferrous heme, NO
binds to ferrous and ferric heme, although the a⁄nity
for NO is strongly dependent on the oxidation state of
the heme. Upon aerobic incubation of ferric HMP with
NAD(P)H it is reduced to the oxygenated ferrous state.
This oxy complex is not stable and, upon exhaustion of
NADH with residual oxygen, decays into a form in which
heme and £avin are oxidized. The reversibility of oxygen
binding and the rapid reassociation kinetics after photo-
dissociation con¢rm the globin-like features of HMP [62].
Addition of dithionite and nitrite to the ferric protein re-
sults in the formation of a nitrosyl complex [62,63].
3.4.2. Reaction kinetics of Hb and £avoHb
An overview of ligand binding kinetics and a⁄nities of
Hb and £avoHb is given in Table 2. For VHb two di¡er-
ent values for oxygen release have been published. Orii
and Webster reported a very fast release of oxygen from
VHb (koff = 5600 s31), a value which is several folds higher
than the rate of any other known Hb [25]. Recent data
indicate a more moderate rate of oxygen release from VHb
(biphasic release with koff = 4.2 s31 (fast phase) and 0.15
s31 (slow phase)) [64]. This biphasic behavior of oxygen
release from VHb has been associated with conformation-
al changes occurring in response to the breakage of hydro-
gen bonds between heme-bound oxygen and Tyr-B10. The
koff values for VHb reported by Giangiacomo et al. [64]
are in good agreement with the data obtained in our lab-
oratory (Farre¤s, J., personal communication).
Replacement of the distal Gln-E7 residue by His had
deleterious e¡ects on oxygen-binding properties of VHb
[56]. Binding of O2 to the mutated protein is impaired
(absence of a stable oxy form), suggesting that the distal
His is coordinating the heme iron and transforming it to a
hexacoordinated state. Interestingly, a change of Gln-E7
to Leu had little e¡ect on oxygen-binding characteristics,
indicating that the distal glutamine does not stabilize the
bound oxygen with a hydrogen bond, a ¢nding supported
by the structural arrangement of the heme pocket [47,56].
3.4.3. Catalytic activities of £avoHbs and Hbs
HMP can mediate electron transfer either from NADH
(via FAD) to a heme-bound ligand such as oxygen (or
NO) or, in the absence of a ligand, from NADH (via
FAD) to an external electron acceptor [65]. In the presence
of oxygen and NADH, HMP has NADH oxidase activity,
which leads to the rapid consumption of NADH and to
the generation of superoxide and H2O2, both in vitro and
in vivo [66,67]. Upon exhaustion of oxygen, the oxygen-
ated species disappears to generate the deoxy-ferrous
heme, whereupon the £avin becomes reduced [68]. Various
electron acceptors are reduced by HMP in vitro, including
dihydropteridine, ferrisiderophores, ferric citrate, cyto-
chrome c, and Fe(III)-hydroxamate [34,65,69,70]. How-
ever, it is unknown if these reactions are of any biological
signi¢cance in vivo [34,70]. Despite the lack of a reductase
domain, puri¢ed, aerobic preparations of VHb generate
hydrogen peroxide in the presence of NADH and O2 in
a 1:1 stoichiometry [71].
3.4.4. Aerobic detoxi¢cation of NO by £avoHb
Gardner et al. [72] identi¢ed an inducible, O2-depen-
dent, cyanide-sensitive, protective enzymatic activity that
is able to shield the NO-sensitive aconitase in E. coli. Ex-
posure of aerobically growing cells to NO elevated this
activity. Gardner et al. [72] and Hausladen et al. [73] at-
tributed the observed NO detoxi¢cation to HMP expres-
sion, which was shown to play a central role in the induc-
ible response to nitrosative stress. The authors stated that
NO detoxi¢cation consumes O2 and NADH and converts
NO and O2 in equistoichiometric amounts to nitrate, and
designated the activity as nitric oxide dioxygenase (NOD)
(Fig. 2).
        
Fig. 2. The reaction mechanism of the HMP-catalyzed NOD reaction as outlined by Gardner et al. [167]. The reaction has been suggested to proceed
via a heme-bound peroxynitrite [52].
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HMP-mediated NO degradation proceeds at a rate of
94 s31 (20‡C) and 240 s31 (37‡C) at an oxygen concentra-
tion of 200 WM and an NO concentration of 1 WM [74,75].
It has been suggested that NOD activity is hampered when
the ratio of NO/O2 exceeds 1:100 [74]. However, no sig-
ni¢cant reduction of NO-degrading activity was observed
for HMP at NO/O2 ratios of 1:20 and 1:10 [31]. Mills et
al. [67] considered an O2 concentration of 35^100 WM to
be required for maximal oxygenase activity in vivo. Below
an O2 concentration of 30 WM, the NOD activity of HMP
was ine¡ective [67]. Substitution of Tyr-B10, a residue
proposed to stabilize the Fe2þ-O2 complex, by Phe, Glu
or His diminished the NOD activity of HMP approxi-
mately 15^35-fold.
Therefore, Hausladen et al. [76] suggested an alternative
enzymatic reaction for HMP with NO: a denitrosylase
activity (O2 nitroxylase). They pointed out that due to
the higher a⁄nity of ferrous HMP for NO, relative to
O2, and the inability to bind O2 in the ferric form,
HMP would preferentially bind NO at biologically rele-
vant O2 concentrations [74,76]. During steady state turn-
over, HMP was found in the ferric state. The formation of
a heme-bound nitroxyl equivalent and its subsequent oxi-
dation is a possible novel enzymatic function of HMP.
Despite the suggested NO inhibition of HMP activity
[67,74], the denitrosylase reaction proceeds at a rate (at
40 WM NO and 10 WM O2) which is only approximately
50% slower than the NO turnover at high O2 concentra-
tions of HMP.
The NOD activity of puri¢ed FHP was determined to
be 7.4 s31 (20‡C) and 120 s31 (37‡C), showing that the
NOD activity of FHP is more temperature dependent than
that of HMP [75]. Furthermore, aerobic NO consumption
in vitro (at 10 WM NO, room temperature) with a con-
comitant formation of nitrate was recently reported for
the £avoHbs from P. aeruginosa (26 s31), K. pneumoniae
(95 s31), Salmonella typhi (76 s31) and B. subtilis (68 s31).
NO turnover of HmpBs was shown to be concentration
dependent (10 WM NO: 68 s31 ; 20 WM NO: 128 s31) [31].
Interestingly, the NO degradation by D. radiodurans £a-
voHb was not signi¢cantly di¡erent from non-enzymatic
NO decay [31].
NO-degrading activity of the single domain proteins
VHb and CHb was also proposed to account for the ob-
served protective e¡ects of these proteins against nitrosa-
tive stress [31,77]. However, in vitro NO-degrading activity
of cell extracts containing either of these proteins was not
signi¢cantly di¡erent from control extracts, suggesting
that a membrane-linked reductase could be involved in
NO detoxi¢cation in vivo [31]. The in£uence of the reduc-
tase domain on NO-degrading activity has therefore been
analyzed more thoroughly. The truncated hemoglobin do-
main of FHP (FHPg) (3.4 s31) displayed a four-fold lower
NO turnover rate than the native FHP (15 s31) [31]. In
contrast, engineered VHb protein, carrying an intramolec-
ular reductase domain originating from FHP, increased
the NO turnover rate by a factor of four, thus highlighting
the importance of the reductase domain for the NO-de-
grading activity [31].
3.4.5. Anaerobic conversion of NO by HMP
Under anaerobic conditions, the reaction of NO with
HMP leads to the generation of nitrous oxide (N2O)
with the concomitant consumption of NAD(P)H. NO
binds to the active site of HMP and is reduced to the
nitroxyl anion, which then reacts via a dimeric intermedi-
ate, forming N2O. This reaction proceeds at a rate of 0.14
s31 (1 WM NO, 37‡C), which is several magnitudes lower
than the rate under aerobic conditions [78]. Recent results
have shown a novel enzymatic activity in E. coli that e⁄-
ciently removes NO under anoxic conditions and which
was identi¢ed as a £avorubredoxin reductase [79^81].
The enzyme has been shown to have an NO turnover
rate of 14.9 [ 6.7 s31, which is independent of the NO
concentration between 1 and 10 WM NO [81].
4. Regulation and function of bacterial £avoHbs and Hbs
4.1. VHb
4.1.1. Regulation of vhb expression
The oxygen-dependent promoter of vhb (Pvhb) is induced
under oxygen-limited conditions in Vitreoscilla [23]. Pvhb
has been characterized in E. coli, and has been shown to
be functional in various heterologous hosts, such as Pseu-
domonas, Azotobacter, Rhizobium etli, Streptomyces sp.,
Serratia marcescens and Burkholderia sp. [82^88]. Pvhb is
maximally induced under microaerobic conditions in both
Vitreoscilla and E. coli, when the dissolved oxygen level is
less than 2% of air saturation [82,89]. Activity of Pvhb in
E. coli is positively modulated by CRP and FNR. Expres-
sion from Pvhb is substantially reduced in strains that are
unable to synthesize CRP or cAMP. Supplementation of
cAMP to a culture of a cya mutant strain increased the
expression level 10-fold [82]. In contrast, a cya deletion
had no e¡ect on x(hmp-lacZ) expression [90]. A CRP-
binding site has been predicted to be centered at 397
[82]. Despite the in£uence of catabolite repression, expres-
sion of reporter enzymes from Pvhb was not di¡erent in
glucose- or glycerol-containing media under carbon-lim-
ited conditions [91]. In an fnr mutant E. coli strain, the
expression from Pvhb was reduced two-fold under micro-
aerobic conditions (fnr mutant: 2.5 Wg CAT mg31 protein,
fnrþ : 5 Wg CAT mg31 protein) [92]. The location of the
FNR-binding site within the promoter structure has been
disputed. Tsai et al. [92] located it at a position typical for
activation (around 341.5), whereas Joshi and Dikshit [93]
located it around 325.5. The latter site shares only limited
homology to the known E. coli (TTGATxxaxATCAAt)
and non-E. coli (TTGATxxxxATCAAg) FNR consensus
sequences [94]. The DNA-binding motifs of CRP (TGT-
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GAxxxxxxTCACAxTT) and FNR are nearly identical,
di¡ering in only one base pair. It has been shown that
switching of the non-congruent base pair in the half-site
motifs of target promoters can result in their in vivo reg-
ulation by the corresponding non-cognate regulator [95].
Thus, it would seem possible that E. coli FNR and CRP
are able to bind to the identical site in Pvhb. Furthermore,
repression of Pvhb can be achieved by the addition of a
complex nitrogen source to the medium (e.g. yeast ex-
tract). This represents a third level of regulation of Pvhb,
whose mechanism has not yet been studied in detail [91].
In bioreactor cultivations, under conditions of maximal
induction, the level of recombinant protein expressed from
Pvhb accounted for up to 10% of total cellular protein [91].
High expression levels, as well as the manifold regulatory
mechanisms, have rendered Pvhb extremely interesting for
applications in biotechnological production processes,
since the induction of promoter activity is readily achieved
by lowering dissolved oxygen concentrations in bioreac-
tors. Thus, expensive chemical inducers, such as IPTG,
can be omitted.
4.1.2. Biochemical function of VHb
Upon expression of VHb in E. coli under oxygen-limited
conditions, recombinant cells grew to higher ¢nal cell den-
sities relative to plasmid-bearing controls [89]. Further ex-
periments showed that the e¡ect of VHb was not restricted
to growth improvements, but also resulted in enhanced
protein synthesis [96]. Tsai et al. [97] showed that, in
E. coli, bene¢cial e¡ects of VHb correlated with VHb ex-
pression levels up to a saturation level (3.4 Wmol VHb g31
cell), above which no further improvements could be ob-
served. Khosla et al. [96] proposed that VHb expression
could facilitate oxygen di¡usion and improve aerobic me-
tabolism in E. coli.
The cellular energetic parameters of VHb-expressing
cells have been analyzed in various E. coli mutants lacking
one or both of the terminal oxidases. Under aerobic con-
ditions, no di¡erences were seen between VHbþ and con-
trol strains independent of the genetic background. How-
ever, under oxygen-limited conditions, the presence of
VHb enhanced the growth rate and ¢nal cell density in a
cyd mutant relative to the corresponding control strain
[98]. Based on these observations, Kallio et al. [98] formu-
lated a hypothesis, stating that the expression of VHb
increases the e¡ective intracellular oxygen concentration
under microaerobic conditions. Such an increase would
shift the relative activity of the terminal oxidases. The
energetically more favorable cytochrome bo3, which pos-
sesses higher proton translocation activity, would predom-
inantly be used in VHb-expressing microaerobic E. coli
cells [98^100].
This hypothesis has been studied in detail and it was
found that expression of VHb increased cytochrome bo3
content ¢ve-fold and cytochrome bd content 1.5-fold rela-
tive to Hb-free controls. No di¡erences in the level of
cytochrome bd were observed in a cyo mutant strain
upon expression of VHb; conversely, VHb expression in
a cyoþ cyd mutant strain led to a two-fold increase in the
amount of cytochrome bo3. Furthermore, it was concluded
that the speci¢c activity of cytochrome bo3 was enhanced
by VHb [97]. Inspection of interactions between VHb and
the various subunits of cytochrome bo3 and bd, using a
yeast two-hybrid system, has veri¢ed the observation
that VHb mainly interacts with cytochrome bo3. VHb
was found to interact speci¢cally with subunit I of the
cytochrome bo3 complexes from Vitreoscilla, E. coli and
P. aeruginosa [101].
As a result of enhanced respiratory activity, VHb-ex-
pressing cells are able to generate a 50% higher proton
£ux per reduced oxygen molecule (relative to a VHb-neg-
ative control) [97,98]. The higher proton £ux led to a 30%
higher ATP synthase activity and a 65% higher net ATP
turnover, thus supporting the model of Kallio et al.
[97,98,102]. Dikshit et al. [103] showed that an E. coli
mutant lacking both terminal oxidases could grow on
the aerobic substrates succinate and lactate when the cells
were engineered to express VHb. These results suggest that
VHb itself might harbor a terminal oxidase function.
However, this potential function of VHb has not been
investigated further and we have not been able to verify
these results using a di¡erent E. coli strain lacking both
terminal oxidases (Kallio, P., personal communication).
Due to the observed interplay of VHb with terminal
oxidase, VHb might a¡ect the electron £ux through the
respiratory chain in E. coli, thus changing the NAD(P)þ/
NAD(P)H ratio and ultimately the £ux through the pri-
mary carbon metabolism. Fluorescence measurements in-
dicated that, near anoxic conditions, the steady state level
of cellular NAD(P)H was 1.8-fold lower in a VHb-express-
ing E. coli strain relative to control cells. Importantly, no
signi¢cant di¡erences in the total NAD(P)þ/NAD(P)H
pool were measured, indicating that the observed reduc-
tion of the NAD(P)H level was due to a shift in the ratio
of the redox couple. The responses to rapidly changing
oxygen tension were slower, suggesting that VHb bu¡ers
the intracellular redox state by sustaining normal respira-
tion during the absence of aeration [104].
Furthermore, VHb-positive cells contained increased
amounts of tRNA’s and active 70S ribosome complexes
under microaerobic conditions in E. coli. This was also
accompanied by a corresponding increase of a marker
enzyme activity [105]. This could be due to an increase
in the amount of available GTP, required for the binding
of tRNA to the small ribosomal subunit during the ¢rst
step of translation initiation. A previous review [106] sum-
marizes the metabolic pathway of inosine-5P-monophos-
phate (IMP), which is a common precursor for both
AMP and GMP. A high ATP concentration favors
GMP synthesis and inhibits the synthesis of IMP from
GMP in E. coli.
Previous energetic experiments revealed that VHb-ex-
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pressing E. coli cells have higher ATP levels [98,107],
which should also lead ultimately to elevated GTP levels
in VHb-expressing strains. VHb-expressing strains have
higher ATP levels, based on one-dimensional 31P nuclear
magnetic resonance measurements, which measure total
NTP levels. A generalized assumption has been made
that the increased NTP peak of VHb-expressing cells is
due to the enhanced production of ATP [98,107]. How-
ever, it cannot be ruled out that the production of either
CTP, TTP or GTP has also increased. It could be possible
that the relative ratio between ATP and GTP, shown to be
approximately 4:1 both in exponentially growing cells and
in stationary phase cultures, has remained the same
[108,109]. VHb-expressing cells may also have higher
GTP levels and faster GTP turnover rates, and for that
reason ribosomes are able to utilize more GTP for protein
synthesis. GTP is also needed for positioning of the large
50S subunit with the initiation complex in prokaryotes.
Thus, elevated GTP levels may also improve the formation
of 70S complexes in VHb-expressing E. coli relative to
controls. A putative explanation for the increased transla-
tional activity and the 3.2-fold enhancement of number of
active 70S ribosomes at the end of the 30-h bioreactor
cultivation, is that VHb-expressing strains have more
ATP and more GTP than the VHb-negative controls.
Lately it has been revealed that VHb protects cells from
nitrosative stress [31,77]. NO-sensitive, cellular respiration
of E. coli cells was protected by the presence of VHb up to
an NO concentration of 10 WM, whereas at 20 WM a more
than 50% reduced respiration rate was reported [77]. In
contrast, the respiration of an HMP-expressing strain
was insensitive to NO up to a concentration of 60 WM
[110]. However, NO detoxi¢cation activity of VHb in vitro
has been judged negligible [31]. Despite the protective ef-
fect of VHb against nitrosative stress in vivo, we could not
detect any induction of Pvhb under such conditions, thus
one may question if VHb would protect its native host
against toxic nitrogen compounds (Frey, A.D., personal
communication). However, activation of Pvhb by FNR
upon shift to oxygen limitation might protect the host
from reactive nitrogen species produced during nitrate/ni-
trite respiration.
4.2. E. coli £avoHb HMP
4.2.1. Regulation of hmp expression
To elucidate possible roles of E. coli HMP protein,
Poole and co-workers [90] have studied hmp regulation
under various growth conditions. Anaerobic expression
is enhanced in an fnr mutant [90]. HMP expression was
stimulated directly by the presence of nitrate (only anaer-
obically) and nitrite. Nitric oxide was found to function as
an inducer under aerobic conditions. The e¡ects of these
nitrogen compounds were mediated independently of
NarLP and SoxRS regulatory systems [90]. Furthermore,
induction of HMP expression was observed in cells enter-
ing the stationary growth phase. This induction is medi-
ated by the stationary phase-speci¢c sigma subunit (cS) of
RNA polymerase [111].
FNR functions as a repressor under anaerobic condi-
tions. An FNR-binding site occurs at positions 32 to +11
in the promoter region (Phmp), and binding of FNR to this
DNA sequence was demonstrated using gel retardation
and DNase I protection assays [90,112]. A mode of Phmp
induction under anoxic conditions involving FNR has
been recently outlined [112]. Based on the observation
that NO is able to reversibly inactivate FNR by nitrosy-
lation, the NO response of a x(hmp-lacZ) fusion was an-
alyzed under anoxic conditions. Upon exposure to NO,
x(hmp-lacZ) was derepressed due to inactivation of
FNR. In the fnr mutant no e¡ect of NO on the dere-
pressed level of x(hmp-lacZ) activity was observed [112].
A⁄nity of FNR to Phmp could be similarly reduced upon
incubation of FNR in presence of O2 and NO. The revers-
ible inactivation of FNR via nitrosylation by NO repre-
sents an alternative pathway for regulation of FNR activ-
ity [112]. As outlined above, the anaerobic NO detoxifying
activity of HMP is only minor and more potent NO de-
toxifying activities exist in E. coli under anoxic conditions.
Induction of hmp expression by NO was shown to be
dependent on MetR, which is the global regulator of the
methionine biosynthetic pathway in E. coli. Two MetR-
binding sites are located in the intergenic region between
hmp and glyA, which are divergently transcribed [113].
Homocysteine is a co-regulator for MetR and mutations
in the methionine pathway (metL), the function of which
is also needed for homocysteine synthesis, made these mu-
tants sensitive to various NO compounds. Upon feeding of
homocysteine to the growing cultures, resistance against
nitrosative stress was restored [114]. MetR has also been
shown to be necessary for induction of x(hmp-lacZ) by
SNP (sodium nitroprusside) and GSNO (S-nitrosogluta-
thione), but only the downstream MetR-binding site is
essential for induction of hmp expression [113]. Induction
occurs upon depletion of homocysteine, which allows
MetR to bind to the promoter region. Inactivation of
homocysteine may occur via a nitrosation reaction [113].
Hmp regulation is also achieved by the addition of an
iron chelator, which induced expression 40-fold under an-
aerobic and ¢ve-fold under aerobic conditions [90]. The
observed stimulation might result from complexing iron
and a subsequent inactivation of the [Fe^S] cluster of
FNR, leading to the derepression of promoter activity.
However, no Fur-binding site is present in the promoter
sequence of hmp, which is in marked contrast to the sit-
uation in Salmonella serovar Typhimurium outlined be-
low.
Membrillo-Herna¤ndez et al. [115] also reported the in-
duction of a x(hmp-lacZ) in the presence of superoxide-
producing paraquat. The induction of sodA-lacZ followed
a subtler pattern, as did the x(hmp-lacZ), the expression
of which was induced only by paraquat concentrations
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above 200 WM. The independence of HMP upregulation
by SoxRS was shown using E. coli mutants of either of
these two transcriptional regulators. Anjum et al. [116]
showed a 28-fold induction of a x(hmp-lacZ) fusion after
a prolonged incubation in the presence of paraquat, a
treatment that induced HMP expression to spectrally de-
tectable levels.
4.2.2. Function of HMP protein
The observation that HMP is an NADH oxidase, and is
thereby able to generate superoxide radicals and H2O2,
was used to formulate the hypothesis that HMP might
be involved in the oxidative stress response in E. coli
[66,67]. Interestingly, HMP not only generates ROS, but
is also needed for full expression of sodA and soxS. Fur-
thermore, an hmp mutant was markedly more sensitive
towards paraquat, particularly at lower paraquat concen-
trations, as shown by a viability assay [117]. Expression of
HMP in E. coli protected cells against paraquat-induced
oxidative stress, as judged from the superior growth be-
havior relative to a control [31]. However, it might be
argued that the role of HMP under oxidative stress might
be dose dependent, since the overexpression of HMP led
to the production of ROS. Poole and Hughes [118] sug-
gested that HMP might act as an ampli¢er of superoxide
stress, leading to the full expression of SoxRS stress re-
sponse.
Various classes of proteins, such as [Fe^S], Cu/Fe or
heme-containing proteins, are considered to be targets of
RNS. Aconitase, a protein containing a radical-sensitive,
labile [Fe^S] center, is a prime target for inactivation by
RNS. The protective activity of HMP was demonstrated
in vivo as well as in vitro [72]. Terminal oxidases contain
both heme and Cu and are main targets of NO inhibition.
Stevanin et al. [57] reported a protective e¡ect of HMP on
the activity of both terminal oxidases in mutant strains
lacking either of the terminal oxidases. Respiration of an
hmp mutant was extremely sensitive to NO and half-max-
imal inhibition was achieved at an NO concentration of
0.8 WM. However, the degree of inhibition increased at low
oxygen concentrations.
4.3. Regulation and function of S. enterica serovar
Typhimurium £avoHb (HmpStm)
The £avoHb of Salmonella serovar Typhimurium
(HmpStm), which shares 94% identity with E. coli HMP,
was shown to provide resistance against various NO do-
nors and acidi¢ed nitrite both aerobically and anaerobi-
cally [35,36]. The wild-type and an isogenic hmp mutant
showed no di¡erences in the minimal inhibitory concen-
trations of paraquat and H2O2. Also, the synergistic ac-
tion of NO- and O32 -forming peroxynitrite did not result
in di¡erences in the viability, thus implying that HmpStm
is exclusively protecting from RNS [35]. Analysis of a
x(hmpStm-lacZ) fusion revealed that the expression in re-
sponse to NO is independent of SoxS, OxyR and FNR
under aerobic conditions. However, in a fur mutant com-
plete derepression of x(hmpStm-lacZ) was observed that
could not be augmented by an NO bolus or by addition of
an iron chelator. A putative Fur-binding box is present in
the promoter region of the hmpStm gene. Additional genes
known to be repressed by Fur were induced by the addi-
tion of NO, thus showing that NO is indeed able to in-
activate Fur. This model of Fur inactivation by NO has
been demonstrated for the Fur protein of E. coli [119].
Induction of x(hmpStm-lacZ) by the iron chelator was
similar in wild-type and hmpStm mutant strains, with
both being insensitive to low iron levels, indicating that
hmpStm expression is exclusively regulated via Fur [36].
Stevanin et al. [110] recently reported some evidence
that HmpStm expression protects cells in vivo, using hu-
man macrophages. A strain with a deleted hmpStm gene
was found to be more sensitive to macrophage-mediated
killing than the wild-type strain. However, for both strains
the number of viable cells was already reduced by approx-
imately 90% 30 min after internalization of the bacteria by
non-activated human macrophages and remained at this
level.
4.4. Regulation and function of R. eutropha £avoHb
(FHP)
FHP expression is 20-fold upregulated under oxygen-
limited conditions in the denitrifying bacterium R. eutro-
pha [13]. Two potential binding motifs for NarL (centered
around 3108) and FNR (centered around 386) in the
upstream non-coding region of fhp have been identi¢ed.
The regulation of FHP by these two global regulatory
molecules suggests a role of FHP in the anaerobic metab-
olism of R. eutropha. Isogenic fhp mutants show no sig-
ni¢cant di¡erences in aerobic or anaerobic growth. How-
ever, the mutant strain did not accumulate nitrous oxide
during denitri¢cation with nitrite as electron acceptor [33].
Recently, the NOD activity of FHP has been demon-
strated, though being ¢ve- to 10-fold lower than the NO
turnover rate of £avoHb from pathogenic bacteria [31,75].
Furthermore, expression of FHP in E. coli cells enhanced
resistance against nitrosative stress [31]. These results sug-
gest that FHP may also protect R. eutropha from NO and
related molecules during denitri¢cation process, which are
unavoidable side products. The intracellular NO concen-
tration during denitri¢cation, however, is tightly con-
trolled by NO reductases [120]. Thus, it is not clear if
the NO detoxifying activity of FHP is of any e¡ect under
denitrifying conditions.
4.5. B. subtilis £avoHb (HmpBs)
x(hmp-lacZ) is induced during nitrate respiration by a
shift to anaerobic conditions, but not during fermentative
growth in B. subtilis [37]. Absence of hmpBs expression
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during anaerobic growth and expression during nitrate
respiration has recently been veri¢ed using two-dimension-
al gel electrophoresis under strictly de¢ned growth condi-
tions [121]. FNR acts as an inducer on hmpBs and is in
turn dependent on ResD-ResE, which controls aerobic
and anaerobic respiration in B. subtilis. In vresDE cells,
induction of hmpBs was 10-fold lower relative to wild-type
cells upon a shift to oxygen limitation, and was abolished
by deletion of fnr and narG. Addition of nitrite, but not
nitrate, restored induction of x(hmp-lacZ) [37]. The con-
clusion is that upon a shift to anaerobiosis nitrate respi-
ration occurs, which is dependent on FNR and narG.
Deletion analysis of regulatory sequences and DNase I
footprinting experiments indicated that the binding site
for ResD is located between 367 and 349 in the promoter
region [122]. Besides controlling anaerobic induction of
hmp, ResDE-dependent genes were shown to respond to
RNS, albeit to di¡erent extents. Deletion of either ResD
or ResE reduced SNP-induced expression, although a
basal expression level was observed in both mutant strains.
Hmp expression is induced 20-fold upon exposure to SNP
(aerobic), and almost 100-fold under anaerobic conditions
in the presence of SNP (200-fold in the presence of NO)
[123], thus indicating that HmpBs also serves to protect
from RNS, which was demonstrated recently [31]. Surpris-
ingly, NO-degrading activity was found to be dependent
on NO concentration under conditions during which other
proteins did not show any response to elevated amounts of
NO [31].
4.6. FlavoHbs from various bacterial species
Little is known concerning the £avoHbs from M. tuber-
culosis (HmpMt) and P. aeruginosa (HmpPa), two patho-
gens which cause severe infections and whose treatment is
impaired due to the occurrence of antibiotic resistance.
HmpMt seems to be mainly induced upon entry into the
stationary phase (¢ve-fold) if the growth is oxygen limited.
Furthermore, a short shift to anaerobic conditions was
able to induce expression [39]. Using microarray technol-
ogy, a comparison of 4-day and 100-day cultures revealed
a 1.8-fold higher expression level of hmpMt at the latter
timepoint [124]. RNS only slightly induced expression of
hmpMt (1.5-fold), and ROS decreased expression by 50%.
Exposure to ROS or RNS had no e¡ect on cell viability.
Besides one £avoHb, M. tuberculosis possesses two addi-
tional globin proteins, which belong to the group of trHb
(HbO and HbN) [19,125].
An interesting observation was recently reported by Fi-
roved and Deretic [126]. Comparison of a mucoid wild-type
to a mucoidy suppressor strain revealed a strong 61-fold
induction of HmpPa expression in the suppressor strain
during the exponential growth phase under aerobic con-
ditions. Furthermore, other genes encoding NO reductase
were also strongly induced (20- to 50-fold). It has been
suggested that the expression of NO detoxifying genes is
upregulated to compensate for the reduced protection nor-
mally provided by the mucoid phenotype. Previously, we
have shown that HmpPa is able to detoxify NO and to
protect a heterologous host against nitrosative stress [31].
Early support for the hypothesis that £avoHb proteins
function as integral components of stress response was
reported by Favey et al. [38]. They showed that upon
inactivation of the £avoHb gene (hmpX) in the plant
pathogen E. chrysanthemi, the bacterium became unable
to infect plant species. This behavior could be attributed
to the reduction in the synthesis of pectate lyases (PL),
which are pathogenicity determinants of E. chrysanthemi
under conditions of low oxygen tension. The synthesis of
PL is abolished in hmpX mutant cells upon infection of
Saintpaulia plants. The regulation of hmpX expression was
also shown to be dependent on plant host factors, as dem-
onstrated by the upregulation of a x(hmpX-gus) by co-
cultivation of E. chrysanthemi in the presence of a tobacco
suspension culture. Microaerobic conditions per se, as en-
countered upon infection, were not su⁄cient to start tran-
scription of a x(hmpX-gus) [38]. The involvement of NO
compounds in the plant defense has been shown [127], and
therefore it is very likely that hmpX expression contributes
to the resistance against RNS radicals.
5. Hbs and £avoHbs in biotechnology
Oxygen is the electron acceptor of choice in allowing the
cell to generate energy in the most e⁄cient way. During
respiratory growth on oxygen, energy is produced by cou-
pling substrate oxidation to the reduction of oxygen. Sub-
strates, such as glucose, pyruvate, lactate and succinate,
are completely oxidized via the tricarboxylic acid (TCA)
cycle with concomitant transfer of electrons to the cellular
quinone pool [128]. The electrons are transferred further
to one of the two terminal oxidases. Cytochrome bo3 is the
terminal oxidase of choice at atmospheric oxygen levels
(Km = 0.35 WM), whereas cytochrome bd is active during
microaerobic growth (Km = 3^5 nM) [99,100,129].
In the absence of oxygen, but in the presence of an
appropriate alternative electron acceptor, E. coli cells can
produce a set of alternative respiratory oxidoreductases,
which catalyze the transfer of electrons to fumarate, ni-
trate, dimethyl sulfoxide or trimethylamine-N-oxide [130,
131]. In the complete absence of oxygen and alternative
electron acceptors, the cellular metabolism of E. coli
switches to fermentative pathways [132]. These catabolic
pathways involve redox-balanced dismutation of the car-
bon source, substrate level phosphorylation and the for-
mation of fermentation products such as acetate, formate
(H2 and CO2), ethanol, lactate and succinate [132].
The switch between di¡erent metabolic modes is accom-
panied by fairly dramatic changes at the transcriptional
level. Two global regulators ensure the expression of the
appropriate enzymatic con¢guration: FNR and ArcAB,
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which both can function synergistically and antagonisti-
cally on the expression of certain genes. Furthermore,
their regulatory function is assisted by other regulatory
proteins, such as NarL/P [128]. These regulatory mecha-
nisms ensure that the energetically most favorable meta-
bolic pathway is used. Thus, oxygen is used in preference
to nitrate, nitrate to fumarate, and fumarate to the endo-
genously generated electron acceptors, which are produced
in the fermentative pathways [133].
The commercial production of a variety of desirable
metabolites and important pharmaceuticals employs the
overexpression capacity of oxygen-requiring bacteria, fun-
gi and mammalian cells. Oxygen has very low solubility in
water and various microorganisms and cultured cell types
have high nutritional demand for oxygen, especially dur-
ing large-scale and high-cell-density production processes.
The high demand for oxygen can be partially satis¢ed by
improving process parameters and bioreactor con¢gura-
tions, e.g. improved mixing rates, high-e⁄ciency disper-
sion systems and modi¢cations of the medium [134].
5.1. Use of VHb to improve cell growth and productivity
Metabolic engineering approaches seek genetic strat-
egies, for example to alleviate adverse e¡ects of oxygen
limitation on microorganisms, higher cells and plants
[135]. The approach is based on previous observations
that Vitreoscilla expresses Hb under oxygen deprivation.
The vhb gene was successfully transferred to E. coli and
upon expression of VHb, growth and protein production
of E. coli was enhanced under microaerobic conditions
[89,96]. The positive e¡ects of VHb expression, promoting
either the e⁄ciency of oxygen-limited growth and/or pro-
duction of primary and secondary metabolites in numer-
ous microorganisms, are well documented (Table 3). This
technology seems to be especially bene¢cial for mycelium-
forming microorganisms, such as the antibiotic-producing
Streptomyces strains, Acremonium crysogenum and Sac-
charopolyspora erythraea. It is known that oxygen transfer
to the mycelial pellet is limited and is especially critical
when such microorganisms are grown in highly viscous
industrial media. In such situations, VHb expression seems
to enhance antibiotic production. The VHb expression
technology has been successfully tested in collaboration
with the biotechnological industry, using an industrial
S. erythraea strain producing erythromycin. The vhb gene
was stably integrated into the genome of S. erythraea us-
ing Streptomyces phage xC31 attachment site [136]. VHb
expression signi¢cantly increased erythromycin produc-
tion, resulting in an enhanced space^time yield of approx-
imately 100% (1.1 g erythromycin l31 day31) relative to
the original strain. The ¢nal erythromycin titer was 7.4 g
l31 after 9 days of cultivation for the engineered strain
(control 4.0 g l31) [137]. Thus, these results show that
this technology may generally be applied to improve the
metabolism of industrially important antibiotic-producing
strains and of other ¢lamentous microorganisms.
2,4-Dinitrotoluene (2,4-DNT) is a serious contaminant
at munitions facilities. The pathway of 2,4-DNT degrada-
tion by Burkholderia sp. strain DNT has been analyzed by
biochemical and genetic means. Oxygen was shown to be
required for three steps in the oxidative degradation path-
way [138]. Thus, VHb technology has been considered
useful to improve the bioremediation capacity of Burkhol-
Table 3
E¡ects of VHb expression on growth and productivity
Organism E¡ects Reference
Acremonium chrysogenum 3.2-fold increase in cephalosporin C production [159]
Bacillus subtilis 30% increase in neutral protease, 7^15% increase in K-amylase activity and 1.5-fold increase in
protein secretion
[160]
Burkholderia sp. 15% increase in biomass and two-fold increase in the rate of DNT degradation [88,139]
Chinese hamster ovary cells 40^100% increase in tissue plasminogen activator production [143]
Corynebacterium glutamicum 30% increase in L-lysine titer and 24% increase in L-lysine yield [161]
Escherichia coli 30% increase in total cell protein, 80% increase in CAT activity, 40% increase in L-galactosidase
activity
[89]
Escherichia coli 61% increase in L-lactamase activity [105]
Escherichia coli 3.3-fold increase in K-amylase activity [162]
Escherichia coli 1.8-fold increase in ferritin production [163]
Nicotiana tabacum 50% faster germination, enhanced growth, 80^100% more dry weight, 30^40% more chlorophyll,
34% more nicotine
[164]
Nicotiana tabacum, suspension culture 10^50% enhanced growth, shortened lag phase [142]
Pseudomonas aeruginosa 11% increase in viable cell number, increased oxygen uptake [165]
Rhizobium etli 68% higher nitrogenase activity in nodules of bean plants and 53% higher total nitrogen content [87]
Saccharomyces cerevisiae three-fold increase in ¢nal cell density [102]
Saccharopolyspora erythraea 70% increase in ¢nal erythromycin titer [136,137]
Serratia marcescens enhancement of acetoin and 2,3-butanediol production, increase in cell size [85,86]
Streptomyces coelicolor 10-fold increase in actinorhodin production [84]
Streptomyces lividans 50% increase in ¢nal cell density [84]
Streptomyces rimosus 2.2-fold increase in oxytetracycline production [144]
Xanthomonas maltophila 15% increase in viable cell number, enhanced degradation of benzoic acid [166]
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deria sp. strain DNT and indeed expression of VHb im-
proved the rate of 2,4-DNT degradation [88]. The en-
hancement of the degradation capacity was shown to be
dependent on culture conditions. Feeding of a co-substrate
increased the total amount of 2,4-DNT removal. Gener-
ally, VHb-expressing strains reached higher ¢nal cell num-
bers at 200 ppm 2,4-DNT, whereas at lower concentra-
tions no di¡erences were seen relative to Burkholderia sp.
strain DNT. Furthermore, the former displayed signi¢-
cantly improved bioremediation characters [139]. How-
ever, it cannot be concluded if the observed e¡ects are
due to an enhanced biodegradative activity or are the re-
sult of the higher cell numbers due to the improved growth
properties of VHb-expressing cells.
The bene¢cial e¡ects of VHb-expression technology
were shown not to be restricted to bacterial organisms.
The use of plants and plant cells for the production of
natural or recombinant compounds has recently gained
momentum [140]. Oxygen supply to plant cells is known
to a¡ect both cell growth and the production of metabo-
lites [141]. Therefore, Farre¤s and Kallio [142] have ex-
pressed VHb suspension cultured tobacco cells. VHb ex-
pression resulted in a shortened lag phase and 10^50%
increased ¢nal cell densities in batch cultures relative to
control cultures. No di¡erences were seen in sucrose con-
sumption or ethanol production [142]. Furthermore, in a
mammalian system, tissue plasminogen activator produc-
tion has been increased 40^100% in VHb-expressing Chi-
nese hamster ovary cells relative to controls [143].
The above-cited results show that heterologous VHb
expression is able to alleviate oxygen limitation in a wide
range of distinct organisms. Thus, the inverse metabolic
engineering approach, i.e. the genetic transfer of useful
phenotypes to heterologous organisms, represents a fast
and e¡ective means to alleviate the adverse e¡ects of oxy-
gen limitation [144].
5.2. Novel globin proteins for improved performance in
heterologous hosts
It has been hypothesized that the biochemical properties
of VHb are not optimized for foreign host cells [145].
Therefore, screening of novel globin proteins and genera-
tion of VHb mutants has been performed to adapt the
VHb technology for certain biotechnological applications.
5.2.1. VHb mutants and single chain variants of VHb
Andersson et al. [145] have used error-prone PCR (poly-
merase chain reaction) to generate a number of randomly
mutated vhb genes. VHb mutants were screened for im-
proved growth properties under microaerobic conditions
in E. coli. Several clones were selected and analyzed to
elucidate the physiological e¡ects of novel VHb proteins.
The expression of four VHb mutants, carried by pVM20,
pVM50, pVM104 and pVM134, was able to enhance mi-
croaerobic growth of E. coli approximately 22% (muta-
tions: Glu-A17 and Glu-H23 to Gly), 155% (His-C1 to
Arg and Gln-E20 to Arg), 50% (Ala-E10 to Gly) and
90% (Ile-B5 to Thr), respectively, with a concomitant de-
crease of acetate excretion into the culture medium. The
e¡ects of the amino acid exchanges on the structure have
not been analyzed in detail. Glu-H23 is part of a H-bond-
ing network at the proximal site of the heme thought to
provide an electronic push and to be partially responsible
for the activation of O2. The absence of this residue might
lower the auto-oxidation rate of the heme and therefore
favor reversible O2 binding. Due to the cloning strategy
used in their construction, the mutated VHb proteins also
contained an extension of eight residues (MTMITPSF) at
their N-termini. The experiments indicated that the posi-
tive e¡ects elicited by mutant VHb expression from
pVM20 and pVM50 were linked to the N-terminal peptide
tail. Removal of the N-terminal sequence from pVM20
and pVM50 reduced cell growth approximately 23% and
53%, respectively, relative to native VHb controls [145].
If criteria other than ¢nal OD600 are applied (e.g. WmaxÞ,
other VHb mutants outperform native VHb. Of the mu-
tants reaching higher ¢nal cell densities, only pVM50 ex-
hibited a higher Wmax (50%) than the strain expressing
native VHb. The strain carrying a Lys-F2 to Asn mutation
grew fastest and had a two-fold higher Wmax, and a His-
BC1 to Arg substitution enhanced Wmax by 50%. Lys-F2
has been predicted to be part of the intramolecular hydro-
phobic zipper observed between helix F and H. These
structures also build the contact region for interaction
between the two VHb subunits. Thus, the quaternary ar-
chitecture might be altered by the Lys-F2 to Asn substi-
tution, e.g. changing the O2-binding kinetics.
The glucose consumption rate and biomass yield on
glucose (Yx=glc) for mutants versus native VHb protein
has yet to be analyzed. However, experiments have re-
vealed that clear di¡erences in Yx=glc exist among strains
expressing various Hbs [30,146]. Our data (Kallio, P., un-
published results) show that growth of cells carrying
pVM50 is already glucose-limited after 10 h of growth,
in contrast to pVM20 and native VHb-expressing cells,
leading to a double limitation (O2 and carbon source).
This clearly indicates that growth protocols, established
for VHb-expressing cells, are not ideally suited to assess
the growth-promoting potential of cells expressing VHb
mutants.
Since VHb exists as a homodimer, it was determined if a
single chain variant containing two vhb genes separated by
a short linker (termed double VHb) could outperform
growth properties of a strain expressing native VHb. Ex-
pression of double VHb, which was judged to be bio-
chemically active, increased ¢nal cell density about 19%
relative to the native VHb-expressing E. coli cells. Based
on a computer model, the authors proposed that forma-
tion of oligomeric structures composed of several double
VHb might occur [147]. However, it has yet to be analyzed
if such structures exist in vivo.
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5.2.2. Screening of £avoHb and Hb proteins and
construction of chimeric proteins
Due to the high structural similarity between VHb and
FHPg, several chimeric protein fusions between VHb and
the reductase constituents of FHP were constructed. Trun-
cated forms of FHP were also generated [148]. Upon ex-
pression of these constructs in microaerobically grown
E. coli cells, increased ¢nal cell densities were observed
after 30-h fed-batch cultivations, relative to control
strains. Expression of the native FHP or the chimeric fu-
sion between VHb and the reductase domain of FHP
(VHb-Red) resulted in an approximately 50% and 75%
higher ¢nal cell density, respectively, relative to the
VHb-expressing strain. Furthermore, all Hb- or £avoHb-
expressing strains accumulated less acetate, indicating a
less anaerobic metabolism [148].
To analyze the primary carbon metabolism of the
strains expressing VHb, FHP, VHb-Red and FHPg, 13C-
labeling experiments were conducted. The active pathway
con¢guration is imprinted into the proteinogenic amino
acids, and analysis of the labeling pattern using nuclear
magnetic resonance spectroscopy subsequently allows cal-
culation of the £ux distribution in the primary carbon
metabolism. [149]. Cells were fractionally labeled with
[13C]glucose during the late-exponential phase, a timepoint
at which growth of control culture ceases rapidly whereas
Hb- or £avoHb-expressing E. coli cells continue to grow.
Interestingly, the carbon routing in microaerobically
grown VHb- or VHb-Red-expressing cells and control
cells was strikingly similar and closely resembled the label-
ing pattern of wild-type E. coli cells grown under anaero-
bic conditions, i.e. the TCA cycle was interrupted and
found to be replenished by the anaplerotic reaction. Fur-
thermore, 70% of acetyl^CoA was synthesized via pyru-
vate^formate lyase (PFL) [146,150]. Additionally, dilution
of the intracellular acetate pool occurred, which is indica-
tive for re-uptake of the excreted acetate (10% of total
amount of acetate). This e¡ect was even stronger if cells
were grown in the presence of excess glucose (30^40% of
intracellular acetate) (Frey, A., personal communication).
In contrast, expression of FHP or FHPg shifted the me-
tabolism to a more aerobic regime, with a functional TCA
cycle and a low or absent PFL activity. PFL has a highly
oxygen-sensitive radical in its active site and is therefore
readily inactivated by the presence of minute amounts of
oxygen. Despite the identical carbon £ux distribution of
VHb- and VHb-Red-expressing cells and control strains,
VHb/VHb-Red-expressing cells still exhibited better
growth and energetic characteristics, i.e. cells grew faster,
displayed a lower production of fermentative byproducts
and a higher oxygen consumption rate, and had an overall
increased Yx=glc [146].
Bollinger et al. [30] have screened various microbial ge-
nomes for the existence of uncharacterized and unidenti-
¢ed Hb and £avoHb genes, which possibly could be used
in biotechnological production processes to improve cell
growth and metabolic properties under oxygen-limited
conditions. Growth behavior and byproduct formation
of E. coli cells expressing various hemoproteins were ana-
lyzed in microaerobic fed-batch cultivations. E. coli cells
expressing £avoHbs from P. aeruginosa, S. typhi and
D. radiodurans grew to similar ¢nal cell densities, as did
the strain expressing VHb (2.98 g l31 cell dry weight).
Although the clones expressing £avoHbs from E. coli,
B. subtilis and K. pneumoniae or the Hb from C. jejuni
outperformed the plasmid-bearing control strain (2.06 g
l31 cell dry weight), these clones did not reach the ¢nal
cell densities measured for VHb-expressing variants. Addi-
tionally, increased Yx=glc was determined for all recombi-
nant strains, and an approximately two-fold Yx=glc en-
hancement was obtained with D. radiodurans £avoHb-
expressing E. coli relative to the E. coli control carrying
the parental plasmid. These results imply that Hb- and
£avoHb-expressing strains are able to utilize the carbon
substrate more e⁄ciently [30].
Saccharomyces cerevisiae £avoHb (Kd = 0.03 WM [75]) or
horse heart myoglobin (Kd = 0.79 WM [151]) did not im-
prove growth of E. coli during microaerobic growth rela-
tive to plasmid-bearing control strains. In contrast, the Kd
for VHb has been reported to be 70 WM [25]. However, as
mentioned before, a second set of kinetic data for VHb
exists, which results in a Kd of 0.02 WM [64], which is
similar to the value reported for the £avoHb of S. cerevi-
siae. These results suggest that the kinetic properties for
oxygen binding and release of the Hb proteins are not
suitable to support microaerobic metabolism of E. coli
as proposed previously [152].
6. Conclusions
Bacterial Hbs and £avoHbs are surprisingly versatile
proteins serving several biological functions, including
protection of the host cell from nitrosative and oxidative
stress and delivering oxygen to respiring cells.
A growing body of evidence has accumulated in the last
few years, demonstrating a role for £avoHbs in the re-
sponse to the threat posed by nitrosative stress. This gen-
eral role of £avoHb in NO defense is of great interest for
clinical microbiology. Pathogenic microorganisms, such as
M. tuberculosis and Salmonella serovar Typhimurium,
might pro¢t from this resistance mechanism upon infec-
tion of a potential host. Bearing in mind the steadily in-
creasing number of antibiotic-resistant pathogens, £a-
voHbs might represent a novel drug target for therapy.
The expression of many £avoHb genes is induced by
environmental stress conditions such as oxygen depriva-
tion or oxidative and nitrosative stress. Several regulatory
proteins have been implicated in the control of gene ex-
pression, such as FNR, ResD/E, Fur, NarL/P, MetR and
stationary phase responsive cS [36,37,39,90]. In general,
induction of £avoHb gene expression is independent of
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the oxidative stress responsive SoxRS and OxyR transcrip-
tion factors [36,37,39,90].
Oxidative and nitrosative stress are common phenom-
ena, caused by exposure of cells to ROS and RNS, both of
which can damage biomolecules such as proteins, nucleic
acids and cellular membranes. Under normal growth con-
ditions, a balance exists between the amount of radicals
produced and the cellular defense mechanisms [153]. De-
fense mechanisms against oxidative and nitrosative stress
are generally under the control of SoxRS and OxyR,
which exist in a variety of bacteria (for review, see
[154]). Exposure to a boost of radicals results in the rapid
induction of adaptive defense enzymes independent of, or
under the control of, SoxRS and OxyR. Various gene
products (e.g. ahpC, metL, noxR1, noxR3, sodA, katG
and gor) have been shown to contribute to this defense,
protecting against either or both kinds of these bacterio-
cidal products [155].
Besides RNS and ROS, which both serve cytotoxic and
immunoregulatory functions, the arsenal of antimicrobial
agents also comprises for example myeloperoxidase, elas-
tase, cathepsin G and phospholipase A2. All of these com-
pounds contribute to the host defense. Knockout studies
in mice showed that, dependent on the pathogen, di¡erent
compounds are essential for the host defense. For exam-
ple, production of ROS by phagocyte oxidase is essential,
whereas RNS produced by inducible nitric oxide synthase
are only contributory to the defense against Salmonella
serovar Typhimurium [156]. Thus, it can be anticipated
that the role of £avoHb in the bacteria’s defense mecha-
nisms is dependent on its host, and its contribution to
overall defense varies among di¡erent organisms.
In contrast to £avoHbs, Hb proteins may serve di¡erent
functions and their exact roles are still poorly de¢ned.
VHb has been widely used to improve growth of a variety
of microorganisms under oxygen-limited growth condi-
tions. The observed bene¢cial e¡ects of VHb expression
on metabolism have been proposed to be linked to in-
creased respiratory activity, i.e. higher oxygen uptake,
higher speci¢c activities of terminal oxidases, speci¢c in-
teraction of VHb with cytochrome bo3 and, therefore, an
overall improved cellular energetic charge.
However, recently two independent studies showed that
VHb is also able to protect cells against RNS and shields
the terminal oxidases from inactivation by NO [31,77]. In
the experiments done so far, it has not been possible to
determine the true mechanism of action of VHb or other
bacterial Hb proteins when expressed in either native or
heterologous hosts. It has been suggested that VHb might
exist in two alternative forms: as a homodimer or as a
heterodimer with a partner reductase [77]. However, the
presence of RNS under standard cultivation conditions in
E. coli is still a matter of debate, in contrast to denitrifying
bacteria, where the production of these reactive molecules
is well documented. The steady state NO concentrations
vary between 1 and 65 nM, depending on species and
growth conditions [120]. In a medium containing nitrite,
the production of NO at acidic pH might occur via pro-
tonation of nitrite and subsequent dismutation into several
species of nitrogen oxides, including NO. Under oxygen-
limited conditions, notable amounts of organic acids are
produced and excreted into the media, lowering the pH,
and formation of RNS might occur under these condi-
tions. Furthermore, NO production can occur endoge-
nously using nitrite as an electron acceptor [157]. In our
experiments, we have observed a low expression of E. coli
hmp in the late-exponential phase of growth and also upon
entering the stationary phase under oxygen-limited condi-
tions (Frey, A. D., personal communication). Induction of
hmp might be an indication of the presence of RNS. Thus,
expression of heterologous £avoHbs and Hbs might im-
prove protection of organisms against RNS and therefore
favor growth of globin-expressing cells. Interestingly, pre-
vention of inhibition of cytochrome activity or increasing
the oxygen supply would result in identical e¡ects, previ-
ously postulated to be due to a higher intracellular oxygen
level.
Protein engineering approaches, either of rational or
random origin or based on evolutionary selection, will
help to improve the properties of globin proteins used in
biotechnological production processes. However, one of
the key limitations in the generation of improved VHb
proteins is the lack of an e⁄cient screening system. Screen-
ing of mutant strains in a de¢ned experimental setup
might result in the selection of phenotypically undesired
mutant strains, since additional parameters might limit
these mutants in outperforming the native protein under
the standard conditions. It is quite obvious that previously
applied methods may have resulted in the selection of a
physiologically unfavorable group of mutants. Therefore,
the exact mechanisms for improving growth and produc-
tivity have to be clari¢ed ¢rst. This knowledge will be
required for the setup of a screening system allowing rapid
and clear identi¢cation of novel proteins with superior
characters.
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